## BACKGROUND. Interferon (IFN) has demonstrated activity in the treatment of patients with multiple myeloma. A previous Eastern Cooperative Oncology Group (ECOG) study suggested that the rates of complete response (CR) and survival were increased with a regimen that alternated IFN with chemothera
✦ LIBER ✦
Randomized trial of α-interferon or dexamethasone as maintenance treatment for multiple myeloma
✍ Scribed by Raymond Alexanian; Donna Weber; Meletios Dimopoulos; Kay Delasalle; Terry L. Smith
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 75 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The addition of interferon or high dose
✍
Martin M. Oken; Traci Leong; Raymond E. Lenhard Jr.; Philip R. Greipp; Neil E. K
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 133 KB
👁 2 views
Randomized trial of treatment with cispl
✍
Thierry Dorval; Sylvie Négrier; Christine Chevreau; Marie-Françoise Avril; Danie
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 88 KB
👁 1 views
## Background: The objective of the current study was to evaluate the response rate, survival, and toxicity of treatment with cisplatin and high dose intravenous continuous infusion interleukin-2 (il-2) with or without interferon-alpha-2a (ifn) in patients with metastatic melanoma. ## Methods: On